Windtree Therapeutics (WINT), a Nasdaq listed biotechnology company, plans to raise up to $200 million to build a treasury of ...

Windtree Therapeutics has entered agreements to raise up to $520 million for BNB cryptocurrency acquisition, with a total commitment nearing $700 million. The company plans to direct 99% of funds ...

Windtree Therapeutics, recently made waves by announcing plans to allocate up to $700 million toward acquiring BNB.

Despite the price drop, BNB is seeing growing corporate adoption, with several companies announcing plans to invest hundreds ...

The rebound was fueled by Windtree Therapeutics' commitment to invest $520 million in BNB for its corporate treasury.

BNB (BNB) price is down slightly to trade at $771 on Friday, after correcting from its new record high of $809, reached on ...

BNB coin price has surged following a treasury strategy announcement from Windtree Therapeutics, a Nasdaq-listed clinical-stage biotech firm.

Nasdaq-listed biotech company Windtree Therapeutics (WINT) announced it has signed a $500 million equity line of credit (ELOC ...

BNB/USDhits a fresh all-time high on positive developments. It hits a high of $855 and is currently trading around $851.50.

About Windtree Therapeutics, Inc. Windtree Therapeutics, Inc. is a diversified company with several divisions, including a cryptocurrency treasury strategy and two promising therapeutic pipelines for ...

Nasdaq-listed Windtree Therapeutics will raise $520 million through an equity line of credit and a stock purchase agreement, for BNB Treasury.